rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Frederick J. Fritz

Director

Company insider

Files Form 4 as: Director, Imunon.

Every Form 4 they filed

In numbers

Trades disclosed
64
Buys
22
Sells
0
Bought
$305K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
8 Jul 2011
Last trade
31 Jul 2026
Last filed
4 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
IMNN ImunonDirector · Biotechnology · last 31 Jul 202622 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
31 Jul 2026filed 4 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$11K6,934 at $1.59filing
31 Jul 2026filed 4 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$11K6,934 at $1.59filing
22 May 2026filed 27 May 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$23K10,330 at $2.20filing
22 May 2026filed 27 May 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$23K10,330 at $2.20filing
2 Jan 2026filed 6 Jan 2026IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—5,892 at $0.00filing
2 Jan 2026filed 6 Jan 2026IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—5,892 at $0.00filing
4 Aug 2025filed 6 Aug 2025IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—250 at $0.00filing
4 Aug 2025filed 6 Aug 2025IMNN ImunonBiotechnologySEC FORM 4 Code A$29K3,161 at $9.20filing
14 Mar 2025filed 18 Mar 2025IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—3,750 at $0.00filing
6 Sep 2024filed 10 Sep 2024IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—6,737 at $0.00filing
12 Jun 2024filed 14 Jun 2024IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—3,500 at $0.00filing
15 Mar 2024filed 18 Mar 2024IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—3,500 at $0.00filing
17 Mar 2023filed 21 Mar 2023IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—2,000 at $0.00filing
13 Jun 2022filed 15 Jun 2022IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
8 Apr 2022filed 11 Apr 2022IMNN ImunonBiotechnologySEC FORM 4 Bought$20K5,000 at $4.05filing
4 Mar 2022filed 7 Mar 2022IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
2 Mar 2022filed 3 Mar 2022IMNN ImunonBiotechnologySEC FORM 4 Bought$9,3802,000 at $4.69filing
7 Oct 2021filed 8 Oct 2021IMNN ImunonBiotechnologySEC FORM 4 Bought$18K20,000 at $0.88filing
19 Mar 2021filed 22 Mar 2021IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
15 Jun 2020filed 16 Jun 2020IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—4,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care22

Buys in green, sells in red, by the company’s sector.

Related people

Michael H. TardugnoExecutive Chairman of Board · Executive Chairman of Board at Imunon, filing Form 4 there in the last year
Stacy LindborgPresident and CEO · President and CEO at Imunon, filing Form 4 there in the last year
Douglas Vincent FallerChief Medical Officer · Chief Medical Officer at Imunon, filing Form 4 there in the last year
Susan EylwardGeneral Counsel and Corp Sec · General Counsel and Corp Sec at Imunon, filing Form 4 there in the last year
Donald P. BraunDirector · Director at Imunon, filing Form 4 there in the last year